AUROPHARMA — Aurobindo Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Aurobindo Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	73,436	33,727	26,125	43,800	50,663
Depreciation
Non-Cash Items	-27,180	2,176	3,419	-254	1,847
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-23,296	2,964	-18,058	-34,417	-29,752
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	33,513	50,132	23,932	24,345	39,253
Capital Expenditures	-18,738	-27,046	-27,204	-35,615	-25,196
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	24,725	-5,069	-12,574	-6,945	6,438
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	5,987	-32,116	-39,778	-42,560	-18,758
Financing Cash Flow Items	-481	-185	-1,112	-2,507	-4,428
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-13,648	-29,693	18,144	8,004	1,198
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	25,831	-11,674	2,298	-10,068	21,784